Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET).
Timothy J. Hobday
No relevant relationships to disclose
Rui Qin
No relevant relationships to disclose
Diane Lauren Reidy
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - ImClone Systems; Merck Sharp & Dohme
Malcolm J Moore
No relevant relationships to disclose
Jonathan R. Strosberg
No relevant relationships to disclose
Andreas Kaubisch
No relevant relationships to disclose
Manisha H. Shah
Research Funding - ImClone Systems; NCI; Novartis
Hedy Lee Kindler
Consultant or Advisory Role - Genentech
Research Funding - Pfizer
Heinz-Josef Lenz
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Helen X. Chen
No relevant relationships to disclose
Charles Erlichman
No relevant relationships to disclose